Skip to main content

Table 1 Demographics and clinical characteristics of the study groups at enrollment.a Each group received EcoVag® capsules containing the mix of L. gasseri DSM 14869 and L. rhamnosus DSM 14870

From: Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection

Groupsa Trial I Trial II
BV
EcoVag®
Group-1 BV EcoVag® Group-2 VVC EcoVag® Group-3 VVC
No EcoVag®
n = 10 n = 9 n = 9 n = 10
Mean age (range) 35.7 (26–49) 30.0 (19–43) 33.4 (23–43) 32.5 (22–43)
Patients with history of BV/VVC (no.) 6 8 9 10
Length of symptoms (months, mean and range) 11 (0.5-30) 17.5 (1–36) 46.6 (12–120) 37.2 (12–120)
  1. n = number of women who completed the study with 6-month follow up
\